Provided by Tiger Trade Technology Pte. Ltd.

Progyny

27.55
+1.646.33%
Post-market: 28.090.5400+1.96%19:49 EDT
Volume:2.26M
Turnover:62.27M
Market Cap:2.11B
PE:30.37
High:28.32
Open:25.81
Low:25.81
Close:25.91
52wk High:33.07
52wk Low:16.10
Shares:76.73M
Float Shares:70.79M
Volume Ratio:2.09
T/O Rate:3.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9071
EPS(LYR):0.6500
ROE:16.24%
ROA:10.14%
PB:4.66
PE(LYR):42.38

Loading ...

Progyny director Kevin K. Gordon disposes of USD 137,445 in common shares

Reuters
·
May 30

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

GlobeNewswire
·
May 28

Progyny shareholders approve charter amendments eliminating supermajority voting requirements

Reuters
·
May 27

Progyny Announces $200 Million Share Repurchase Authorization

TIPRANKS
·
May 26

Progyny Approves Up to $200 Million Stock Buyback Plan

MT Newswires Live
·
May 26

Progyny launches share buyback program of up to $200 million

Reuters
·
May 26

Progyny Inc - Approves Share Repurchase Program for up to $200 Mln of Common Stock

THOMSON REUTERS
·
May 26

Progyny, Inc. Announces Share Repurchase Program

THOMSON REUTERS
·
May 26

Progyny CFO Mark S. Livingston sells 8,275 shares worth $210,012.50

Reuters
·
May 22

Progyny COO Melissa Cummings sells 9,578 shares worth $239,450

Reuters
·
May 22

Positive Report for Progyny (PGNY) from Goldman Sachs

TIPRANKS
·
May 20

Progyny Raised to Buy From Hold by Canaccord Genuity

Dow Jones
·
May 19

Canaccord Genuity Upgrades Progyny to Buy From Hold, Adjusts PT to $30 From $19

MT Newswires Live
·
May 19

Progyny upgraded to Buy from Hold at Canaccord

TIPRANKS
·
May 19

U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology

Reuters
·
May 19

Progyny Is Maintained at Overweight by Barclays

Dow Jones
·
May 18

Progyny price target raised to $27 from $23 at Barclays

TIPRANKS
·
May 18

Progyny price target raised to $27 from $23 at Barclays

TIPRANKS
·
May 16

Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH), Bristol-Myers Squibb (BMY) and Progyny (PGNY)

TIPRANKS
·
May 13

KeyBanc sees modest Progyny TAM impact from DOL fertility carve-out

TIPRANKS
·
May 13